Josephine Walton
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Immune cells in cancer 2
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 4
-
- CRISPR and Genetic Engineering 4
- Cell death mechanisms and regulation 1
- Ubiquitin and proteasome pathways 1
-
- Virus-based gene therapy research 1
- Co-authors
- Iain A. McNeishKaren BlythSusan MasonKaren H. VousdenJulianna BlagihSuzanne DowsonDavid StevensonMalcolm Farquharson
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Josephine Walton
9 papers receiving 426 citations
Peers
Comparison fields: 5 of 52
- Oncology 248
- Immunology 177
- Reproductive Medicine 57
- Cancer Research 83
- Biotechnology 40
Countries citing papers authored by Josephine Walton
This map shows the geographic impact of Josephine Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josephine Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josephine Walton more than expected).
Fields of papers citing papers by Josephine Walton
This network shows the impact of papers produced by Josephine Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josephine Walton. The network helps show where Josephine Walton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Josephine Walton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2020 | 122 | |
| 4 | 2019 | 70 | |
| 5 | 2019 | 1 | |
| 6 | 2018 | 1 | |
| 7 | CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity | 2017 | 2 |
| 8 | 2017 | 18 | |
| 9 | 2017 | 66 | |
| 10 | 2016 | 150 |
About Josephine Walton
Josephine Walton is a scholar working on Reproductive Medicine, Oncology and Molecular Biology, having authored 10 papers that have together received 432 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Immune cells in cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Virus-based gene therapy research (1 paper), Cell death mechanisms and regulation (1 paper), CAR-T cell therapy research (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (248 citations), Immunology (177 citations) and Reproductive Medicine (57 citations). Josephine Walton has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Iain A. McNeish, Karen Blyth, Susan Mason, Karen H. Vousden, Julianna Blagih, Suzanne Dowson, David Stevenson, Malcolm Farquharson, Clare Orange and Dimitris Athineos. Their work appears in journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.